FDA Investigator Josh Renzo N Ramilo
Josh Renzo N Ramilo has conducted inspections on 15 sites in 2 countries as of 31 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
31 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India
FDA Investigators that have inspected at least one site in common with Josh Renzo N Ramilo:
Addam S Reynolds,
Adetutu M Gidado,
Alberto A Viciedo,
Alice S Tsao,
Allen Lou,
Amatul H Marium,
Amit Kokate,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Anita R Michael,
Ankur C Patel,
Anthony J Donato,
Asia D Clark,
Bijoy Panicker,
Craig D Zagata,
Daniel J Grabicki,
Douglas C Kovacs,
Eric Rothschild,
Erin D Mccaffery,
Frederick F Razzaghi,
Gam S Zamil,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
Jazmine N Brown,
Jessica S Estriplet,
Jill M Sooter,
Jill Mielziner,
John D Mcintosh,
Johnna L Bleem,
Jose M Cayuela,
Josh Renzo Ramilo,
Juanita P Versace,
Karen E D'orazio,
Karishma G Gopaul,
Kelli F Dobilas,
Kenneth M Gordon,
Kristy A Zielny,
Larry Johnson,
Lawrence R Johnson,
LCDR Susan E Polifko,
Li Li,
Marcia D Fields,
Margaret M Sands,
Maria Estrella,
Marisa R Eschmann,
Masfin Abdi,
Meyer J Slobotsky,
Michael A Taylor,
Michael R Klapal,
Monika Borkowska,
Nancy F Scheraga,
Niketa Patel,
Paul L Bellamy,
Peter R Lenahan,
Regina T Brown,
Robin P Mathew,
Rose Ljean Mary,
Russell J Glapion,
Samir C Gala,
Satheesh Thomas,
Sinai I Davis,
Sony Mathews,
Stephen J Mottola,
Stephenie M Ortiz,
Suchan Kim,
Susan F Laska, MS,
Thomas E Friel,
Unnee Ranjan,
Victoria Spivak,
William J Leonard,
Youkeun Kim,
Yvesna C Blaise,
Zakaria I Ganiyu,
Zhe J Tang
Josh Renzo N Ramilo's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2022 | EIR | New Jersey Laboratories - EIR, 2022-09-22 |
August, 2023 | FDA 483 | Inopak Ltd - Form 483, 2023-08-03 |
November, 2022 | FDA 483 | Pharmacy Innovations - Form 483, 2022-11-30 |
September, 2022 | FDA 483 Response | New Jersey Laboratories - Form 483R, 2022-09-22 |
March, 2023 | FDA 483 | Saptalis Pharmaceuticals LLC - Form 483, 2023-03-17 |
April, 2024 | FDA 483 | Applechem, Inc. - Form 483, 2024-04-02 |
September, 2022 | FDA 483 | New Jersey Laboratories - Form 483, 2022-09-22 |
January, 2024 | FDA 483 | First Time US Generics LLC - Form 483, 2024-01-12 |
January, 2023 | FDA 483 | SOFIE Co. dba SOFIE - Form 483, 2023-01-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more